NCYT:LON
Novacyt SA
39,50 GBX
arrow_downward
-0,25%(-0,100) 1 d.
16. 10., 16:35:25 GMT+1 · GBX
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre NCYT…
Otvoriť
39,60 GBX
Vysoká
39,68 GBX
Nízka
39,20 GBX
Trh. kap.
32,41 mil.
Priem. obj.
102,63 tis.
Objem
12,22 tis.
Max. za 52 týž.
86,00 GBX
Min. za 52 týž.
26,60 GBX
Akcie v obehu
37,66 mil.
Počet zamestnancov
228
Otvoriť
39,60 GBX
Vysoká
39,68 GBX
Nízka
39,20 GBX
Trh. kap.
32,41 mil.
Priem. obj.
102,63 tis.
Objem
12,22 tis.
Max. za 52 týž.
86,00 GBX
Min. za 52 týž.
26,60 GBX
Akcie v obehu
37,66 mil.
Počet zamestnancov
228
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Yahoo! Finance Canada
·
pred 30 minútami
NTHI,VITL,TRIN,HERZ,SRAD,EFOR,FFIN,AVBC,NXRT,BBSI,BLCO,CULP,VSNT,VIRC,GRNT,SSP,GAIA,CSPI,AFCG,AWRE,APCX,KLTR,AUBN,BETR | Stock Prices | Quote Comparison
The Motley Fool
·
pred 20 minútami
Should You Invest in the S&P 500 Right Now or Wait? There's 1 Clear Answer
Simply Wall Street
·
pred 21 minútami
Warner Music Group (WMG) Draws Fresh Interest, Is A 17% Discount Still On Offer?
Yahoo Finance
·
pred 7 hodinami
Michael Burry Warns of a Stock Market ‘Supervolcano’
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Informácie o subjekte Novacyt SA
Generálny riaditeľDavid Allmond
Zamestnanci228
Dátum založenia3. 7. 2006
Hlavné sídlo-
Odvetvie-
Webnovacyt.com